Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 21 results for "ajanta pharma"

USFDA completes inspection of Dahej unit: Ajanta Pharma
Money Control

US go-ahead to lift Ajanta Pharma

Dahej plant was set up in 2014 to meet Ajanta's requirements for the US and emerging markets Business Standard, 2 weeks ago
Ajanta Pharma rises after USFDA clears Dahej facility Business Standard, 2 weeks ago
[x]  

33 images for ajanta pharma

Money Control, 1 week ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Control, 2 days ago
Money Control, 1 month ago
Money Control, 2 months ago
Financial Express, 3 months ago
india.com, 3 months ago
India.com, 3 months ago
India Infoline, 2 months ago
Money Control

Resistance for Nifty at 9300-9414; buy Ajanta Pharma: Prakash Gaba

Prakash Gaba of prakashgaba.com is of the view that Nifty has support at 9200 and resistance at 9300-9414 while Bank Nifty has support at 21500 and resistance at 22000.
 Money Control3 weeks ago Support for Nifty at 9100-9050; buy Castrol India, Ajanta Pharma: Prakash Gaba  Money Control1 month ago

Ajanta Pharma gains 3% on amalgamation, interim dividend approval

The company has also approved the payment of interim dividend of Rs 7 (350 percent) per equity shares for the FY 2016-17.
 Money Control1 month ago

Divis Lab, Cipla, Strides Shasun to get astro support: Gupta

According to Satish Gupta of astrostocktips, pharma stocks like Divis Lab, Cipla, Alembic Pharma, Strides Shasun, Ajanta Pharma and Torrent Pharma will get astro support.
 Money Control1 month ago

KEC International leads losers in 'A' group

JSW Steel, Jindal Steel & Power, Ajanta Pharma and Idea Cellular are among the other losers in the BSE's 'A' group today, 27 March 2017.
 Business Standard1 month ago
Rediff.com

Note ban shadow lingers over one in four BSE 200 stocks

Quite a few large- and mid-cap stocks are yet to recover from the note ban, pharma, banking and rural demand-based industries among laggards. The S&P BSE Sensex may have recovered from demonetisation to touch a new high of 29,649 points recently, but quite a few large- and mid-cap stocks are yet to recover from the note ban. Nearly 28% of the BSE 200 stocks trade below their November 8, 2016, levels. These include IDFC Bank, Dr Reddy’s Laboratories, Reliance Communications, United ...
 Rediff.com1 month ago

Vice President Ansari's visit will pave way for business opportunity: Honorary consul to Uganda

[Uganda], Feb. 22 (ANI): Honorary Consul Consulate of the republic of Uganda Madhusudan Agrawal on Wednesday hailed the visit of Vice President Hamid Ansari to the African nation, saying his visit would pave way for more business opportunities for the Indian ...
 Sify2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less